Ajooni Biotech

29
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE820Y01021
  • NSEID: AJOONI
  • BSEID:
INR
4.33
-0.03 (-0.69%)
BSENSE

Dec 17

BSE+NSE Vol: 211179

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 43.16% vs 7.55% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 65.09% vs -19.23% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -39.97% vs 16.43% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 56.02% vs 92.16% in Mar 2024

Compare Profit and Loss Results of Ajooni Biotech
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
114.00
285.00
-171.00
-60.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
114.00
285.00
-171.00
-60.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-2.00
2.00
100.00%
Raw Materials Consumed
97.00
269.00
-172.00
-63.94%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
2.00
2.00
0.00
0.00%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
0.00
6.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
111.00
275.00
-164.00
-59.64%
Operating Profit (PBDIT) excl Other Income
3.00
10.00
-7.00
-70.00%
Other Income
2.00
0.00
2.00
0%
Operating Profit (PBDIT)
5.00
11.00
-6.00
-54.55%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
5.00
10.00
-5.00
-50.00%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
4.00
9.00
-5.00
-55.56%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
9.00
-5.00
-55.56%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
3.00
7.00
-4.00
-57.14%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8.00
61.00
-53.00
-86.89%
Profit Available for appropriations
12.00
69.00
-57.00
-82.61%
Appropriations
12.00
69.00
-57.00
-82.61%
Equity Dividend (%)
0%
10%
-10.00
Earnings Per Share
0.2
23.02
-22.82
-99.13%
Profit And Loss - Net Sales
Net Sales 114.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 43.16% vs 7.55% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.69 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 65.09% vs -19.23% in Mar 2024

Profit And Loss - Interest
Interest 0.33 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -39.97% vs 16.43% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 3.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 56.02% vs 92.16% in Mar 2024